Correlation Between OLIPASS and PanGen Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OLIPASS and PanGen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OLIPASS and PanGen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OLIPASS and PanGen Biotech, you can compare the effects of market volatilities on OLIPASS and PanGen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OLIPASS with a short position of PanGen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of OLIPASS and PanGen Biotech.

Diversification Opportunities for OLIPASS and PanGen Biotech

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between OLIPASS and PanGen is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding OLIPASS and PanGen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PanGen Biotech and OLIPASS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OLIPASS are associated (or correlated) with PanGen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PanGen Biotech has no effect on the direction of OLIPASS i.e., OLIPASS and PanGen Biotech go up and down completely randomly.

Pair Corralation between OLIPASS and PanGen Biotech

Assuming the 90 days trading horizon OLIPASS is expected to generate 0.95 times more return on investment than PanGen Biotech. However, OLIPASS is 1.05 times less risky than PanGen Biotech. It trades about 0.27 of its potential returns per unit of risk. PanGen Biotech is currently generating about 0.18 per unit of risk. If you would invest  471,000  in OLIPASS on August 30, 2024 and sell it today you would earn a total of  168,000  from holding OLIPASS or generate 35.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

OLIPASS  vs.  PanGen Biotech

 Performance 
       Timeline  
OLIPASS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OLIPASS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, OLIPASS is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
PanGen Biotech 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PanGen Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, PanGen Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

OLIPASS and PanGen Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OLIPASS and PanGen Biotech

The main advantage of trading using opposite OLIPASS and PanGen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OLIPASS position performs unexpectedly, PanGen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PanGen Biotech will offset losses from the drop in PanGen Biotech's long position.
The idea behind OLIPASS and PanGen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like